Advertisement
Liquidia Corporation

Liquidia Corporation (LQDA) Stock Overview

Explore Liquidia Corporation’s financial performance, market position, analyst ratings, and future outlook.

LQDANASDAQ
HealthcareBiotechnology
$65.25
$1.24(1.94%)
U.S. Market opens in 15h 1m
Advertisement

Liquidia Corporation (LQDA)

Meyka AI Score

Z

Key Financials

Market Cap5.8B
P/E Ratio258.75
EPS (TTM)$0.17
ROE0.47%
Fundamental Analysis

AI Price Forecasts

1 Month$33.83
3 Months$43.76
1 Year Target$49.34

LQDA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Liquidia Corporation (LQDA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 70.11, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $49.34.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 258.75 and a market capitalization of 5.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.94%
5-Day Change
3.97%
1-Month Change
54.26%
3-Month Change
68.04%
6-Month Change
99.66%
Year-to-Date (YTD) Change
89.19%
1-Year Change
335.58%
3-Year Change
698.65%
5-Year Change
2272.73%
All-Time (Max) Change
487.84%

Contact Information

919 328 4400
419 Davis Drive, Morrisville, NC, 27560

Company Facts

170 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading

Frequently Asked Questions